Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.58)
# 830
Out of 5,134 analysts
140
Total ratings
54.74%
Success rate
4%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $415 → $385 | $289.09 | +33.18% | 18 | Jan 28, 2026 | |
| HCA HCA Healthcare | Maintains: Outperform | $500 → $540 | $534.78 | +0.98% | 13 | Jan 28, 2026 | |
| EHAB Enhabit | Upgrades: Outperform | $14 | $11.29 | +24.00% | 3 | Jan 22, 2026 | |
| EVH Evolent Health | Maintains: Outperform | $18 → $12 | $2.72 | +341.18% | 1 | Nov 12, 2025 | |
| GRDN Guardian Pharmacy Services | Initiates: Outperform | $30 | $32.65 | -8.12% | 1 | Oct 10, 2025 | |
| CHE Chemed | Maintains: Outperform | $650 → $580 | $473.06 | +22.61% | 13 | Jul 31, 2025 | |
| CNC Centene | Maintains: Outperform | $51 → $43 | $41.23 | +4.29% | 19 | Jul 28, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $184.99 | +67.58% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $290.71 | +28.99% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $4.56 | +163.16% | 11 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $37 | $31.85 | +16.17% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $165 → $168 | $212.47 | -20.93% | 8 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $145 | $113.26 | +28.02% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $41.01 | -2.46% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.44 | +45.35% | 10 | Jul 25, 2024 |
UnitedHealth Group
Jan 28, 2026
Maintains: Outperform
Price Target: $415 → $385
Current: $289.09
Upside: +33.18%
HCA Healthcare
Jan 28, 2026
Maintains: Outperform
Price Target: $500 → $540
Current: $534.78
Upside: +0.98%
Enhabit
Jan 22, 2026
Upgrades: Outperform
Price Target: $14
Current: $11.29
Upside: +24.00%
Evolent Health
Nov 12, 2025
Maintains: Outperform
Price Target: $18 → $12
Current: $2.72
Upside: +341.18%
Guardian Pharmacy Services
Oct 10, 2025
Initiates: Outperform
Price Target: $30
Current: $32.65
Upside: -8.12%
Chemed
Jul 31, 2025
Maintains: Outperform
Price Target: $650 → $580
Current: $473.06
Upside: +22.61%
Centene
Jul 28, 2025
Maintains: Outperform
Price Target: $51 → $43
Current: $41.23
Upside: +4.29%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $184.99
Upside: +67.58%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $290.71
Upside: +28.99%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $4.56
Upside: +163.16%
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $31.85
Upside: +16.17%
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $212.47
Upside: -20.93%
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $113.26
Upside: +28.02%
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $41.01
Upside: -2.46%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.44
Upside: +45.35%